SLS financials
SELLAS Life Sciences (SLS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
SLS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | -$28.27M | -$26.86M | -0.25 |
| 2024 | $0.00 | $0.00 | -$31.51M | -$30.88M | -0.50 |
| 2023 | $0.00 | $0.00 | -$37.87M | -$37.34M | -1.34 |
| 2022 | $1.00M | $900.00K | -$41.95M | -$41.30M | -2.13 |
| 2021 | $7.60M | $7.40M | -$25.29M | -$20.70M | -1.34 |
| 2020 | $1.90M | $1.90M | -$16.98M | -$16.76M | -2.11 |